LogicBio Therapeutics logo
LogicBio Therapeutics LOGC
$ 7.1 1.94%

Quarterly report 2022-Q3
added 11-14-2022

report update icon

LogicBio Therapeutics EV/EBITDA Ratio 2011-2024 | LOGC

Annual EV/EBITDA Ratio LogicBio Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.13 -4.19 -4.96 1.68 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.68 -4.96 -2.15